Abstract:: The low solubility of an active pharmaceutical ingredient particularly biopharmaceutics classification system (BCS) Class II drugs leads to a lower dissolution profile, which in result causes a reduction in the overall bioavailability of drugs. Numerous approaches like nanotechnology, solid dispersion technique, micronization techniques, etc were aimed by scientists in the past to resolve this issue, but still not enough to get the desired outcomes. : Key focus of this review is the study of the advantages and disadvantages of cocrystallization, nanotechnology and solid dispersions drug delivery techniques and the benefits of using cocrystallization techniques over the above-mentioned techniques. : Various parameters including pharmaceutical, pharmacological and toxicological effects related to these mentioned drug delivery systems have been compared. Their advantages and disadvantages have been elaborated. : For drug delivery purpose, the cocrystallization process has numerous advantages over nanotechnology and solid dispersions drug delivery techniques discussed in the text. Cocrystallization is a newer technique that can modify the physicochemical and pharmaceutical properties of active pharmaceutical ingredients (API) with low solubility, low stability or sensitivity toward environmental hazards like temperature, moisture or photostability issues. During cocrystallization, the drug and the coformer interact with each other non-covalently in a fixed stoichiometric ratio. The availability of a large number of coformers makes this technique to be favorable for the researchers in designing cocrystals of newer and older API’s. : Although solid dispersions and nanotechnology techniques are being utilized to a larger extent, still there are some drawbacks of these techniques like stability, toxicological factors and protection from environmental factors that need to be considered, while the cocrystallization process drastically modifies the various pharmaceutical parameters without altering the pharmacological properties of API’s. Here in this review, we performed a comparative analysis between nanotechnology, solid dispersion and cocrystallization techniques along with the importance of cocrystallization in the modification of drug profile and various applications in the pharmaceutical and allied industry.

Amorphous systems for delivery of nutraceuticals: challenges opportunities

Recent Advances in Enhancement of Dissolution and Supersaturation of Poorly Water-Soluble Drug in Amorphous Pharmaceutical Solids: A Review

Recent Patents on Solid Dispersions Emphasize Promising Benefits in Solubility Enhancement of Poorly Water-soluble Drugs

Drug complexes: Perspective from Academic Research and Pharmaceutical Market

Pharmaceutical Cocrystals: A Novel Systematic Approach for the Administration of Existing Drugs in New Crystalline Form

Navigating the Solution to Drug Formulation Problems at Research and Development Stages by Amorphous Solid Dispersion Technology

Advancement in Solubilization Approaches: A Step towards Bioavailability Enhancement of Poorly Soluble Drugs

Maillard conjugate-based delivery systems for the encapsulation, protection, and controlled release of nutraceuticals and food bioactive ingredients: A review

Pharmaceutical amorphous solid dispersion: A review of manufacturing strategies

A Comparative Study of Selected Drug Delivery Systems: Key Emphasis on Cocrystallization

"Enhancing Oral Drug Absorption: Overcoming Physiological and Pharmaceutical Barriers for Improved Bioavailability"

Oral Bioavailability: Issues and Solutions via Nanoformulations

Amorphous Solid Dispersions (ASDs): The Influence of Material Properties, Manufacturing Processes and Analytical Technologies in Drug Product Development

Bioavailability Enhancement Techniques for Poorly Aqueous Soluble Drugs and Therapeutics

Continuous Manufacturing and Molecular Modeling of Pharmaceutical Amorphous Solid Dispersions

Advancements in Nutraceutical Delivery: Integrating Nanotechnology and Microencapsulation for Enhanced Efficacy and Bioavailability

Challenges of peptide and protein drug delivery by oral route: Current strategies to improve the bioavailability

Drug-drug co-amorphous systems: An emerging formulation strategy for poorly water-soluble drugs

Nanostructured lipid carriers: A platform to lipophilic drug for oral bioavailability enhancement

Particle Size Reduction Techniques of Pharmaceutical Compounds for the Enhancement of Their Dissolution Rate and Bioavailability

Amorphous solid dispersion to facilitate the delivery of poorly water-soluble drugs: recent advances on novel preparation processes and technology coupling